Results 121 to 130 of about 63,125 (274)

Penerapan Pembelajaran Tata Cara Haji Menggunakan Augmented Reality

open access: hybrid, 2023
Dian Agustina   +3 more
openalex   +2 more sources

A cybersecurity risk analysis framework for systems with artificial intelligence components

open access: yesInternational Transactions in Operational Research, Volume 33, Issue 2, Page 798-825, March 2026.
Abstract The introduction of the European Union Artificial Intelligence (AI) Act, the NIST AI Risk Management Framework, and related international norms and policy documents demand a better understanding and implementation of novel risk analysis issues when facing systems with AI components: dealing with new AI‐related impacts; incorporating AI‐based ...
J.M. Camacho   +3 more
wiley   +1 more source

De cara com as drogas!

open access: gold, 2020
Sarah Geysa de Oliveira Ribeiro   +3 more
openalex   +1 more source

Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort

open access: yesACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Objective Multisystem inflammatory syndrome in children (MIS‐C) is a rare hyperinflammatory syndrome that follows SARS‐CoV‐2 infection. Prior plasma proteomic analysis from a 2020 cohort of patients with MIS‐C at our center revealed a profile characterized by thrombotic microangiopathy (TMA), macrophage activation syndrome (MAS)‐associated proteins ...
Sarah McCuaig   +8 more
wiley   +1 more source

Short communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA‐122 in hospital clinical laboratories

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 612-618, February 2026.
MicroRNA‐122 (miR‐122) is a sensitive biomarker for paracetamol‐induced liver injury. This study assessed the diagnostic performance of dynamic chemical labelling (DCL) combined with an immunoassay platform to quantify miR‐122 in human serum, as a proof‐of‐concept for hospital use.
Samar Alzeer   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy